While these findings highlight the importance of FSH and its receptor (FSHR) in bone and brain health, there remains uncertainty regarding whether elevated FSH levels or decreased estrogen levels are the primary drivers of postmenopausal osteoporosis. This evidence concerns the gene BRD2 and postmenopausal osteoporosis.